tiprankstipranks

Peter Flynn Insider Profile

4 Followers
Peter Flynn, Senior Vice President, Early Program Development at Fate Therapeutics, holds 1.24K shares in Orexigen (Ticker: OREXQ), holds 6.50K shares in Fate Therapeutics (Ticker: FATE).
tipranks
Peter Flynn

Peter Flynn
Fate Therapeutics (FATE)
Senior Vice President, Early Program Development

Not Ranked
Peter Flynn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27K
100.00%
A breakdown of Peter Flynn's holdings

Insider Roles

Fate Therapeutics
(FATE)
Senior Vice President, Early Program Development
Roles that Peter Flynn holds in companies

Most Profitable Insider Trade

Stock:
Fate Therapeutics
(FATE)
Rating:Informative Sell
Date:Apr 04, 2014 - Apr 04, 2015
Return:+42.10%
The most profitable trade made by Peter Flynn

Peter Flynn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fate Therapeutics
Jan 07, 2015
Senior Vice President, Early Program Development
Uninformative Buy
$26.54K
OREXQ
Orexigen
Jul 14, 2016
Uninformative Buy
$6.18
List of latest transactions for each holding click on a transaction to see Peter Flynn's performance on stock

Peter Flynn insider profile FAQ

What is the percentage of profitable transactions made by Peter Flynn?
The percentage of profitable transactions made by Peter Flynn is ―.
    What is the average return per transaction made by Peter Flynn?
    The average return per transaction made by Peter Flynn is ―.
      What stocks does Peter Flynn hold?
      Peter Flynn holds: FATE, OREXQ stocks.
        What was Peter Flynn’s latest transaction?
        Peter Flynn latest transaction was an Uninformative Buy of ―.
          What was Peter Flynn's most profitable transaction?
          Peter Flynn’s most profitable transaction was an Informative Sell of FATE stock on April 4, 2014. The return on the trade was 42.10%.
            What is Peter Flynn's role in Fate Therapeutics?
            Peter Flynn's role in Fate Therapeutics is Senior Vice President, Early Program Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.